Schiff Nutrition International, Inc. Announces Fiscal 2007 Third Quarter Results

SALT LAKE CITY, Apr 12, 2007 (BUSINESS WIRE) -- Schiff Nutrition International, Inc. (WNI) , today announced results for the fiscal 2007 third quarter and nine months ended February 28, 2007.

Schiff Nutrition's net sales were $45.0 million for the third quarter of fiscal 2007, compared to $49.6 million for the same period in fiscal 2006. Net income was $3.2 million, or $0.12 per share, for both the fiscal 2007 third quarter and the fiscal 2006 third quarter.

Schiff Nutrition's net sales were $129.5 million for the nine months ended February 28, 2007, compared to $133.1 million for the same period in fiscal 2006. For the first nine months of fiscal 2007, Schiff Nutrition reported net income of $8.8 million, or $0.32 per diluted share, compared to $9.7 million, or $0.36 per diluted share, for the same period a year ago. Fiscal 2006 nine month results were favorably impacted by the incremental recognition of approximately $2.0 million in reimbursement of import related costs, the recognition of approximately $1.6 million of non-taxable foreign currency related gain, and an overall effective tax rate of approximately 19.6 percent.

Bruce Wood, President and Chief Executive Officer, stated, "We experienced very intense competitive conditions during the third quarter, with incremental promotion spending contributing to the net sales decrease versus the prior year quarter. A decline in branded sales was partially offset by strength in our private label business. While the sales decrease resulted in a reduction in gross margin dollars, we are encouraged by the continued improvement in gross profit percentage."

Wood added, "We remain confident in the long term prospects for our Schiff(R) branded business, despite the difficult sales comparatives for the third quarter and the ongoing competitive conditions. We expect to continue our investment behind the Schiff business, with emphasis on our Move Free(R) brand. We plan to leverage our strong financial position in this regard, as we look ahead to fiscal 2008."

About Schiff Nutrition
Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United States and throughout the world. To learn more about Schiff, please visit the web site

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on management's beliefs and assumptions, current expectations, estimates, and projections. These statements are subject to risks and uncertainties, certain of which are beyond the company's ability to control or predict, and, therefore, actual results may differ materially. Schiff Nutrition disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

Important factors that may cause these forward-looking statements to be false include, but are not limited to: the level of customer and consumer acceptance of Move Free(R) Advanced, the inability to successfully implement marketing and spending programs behind our Move Free brand and other new branded products, the impact of raw material pricing, availability and quality (particularly relating to joint care products and ingredients from suppliers outside the United States), the mix between branded and private label products, the ability to grow and/or maintain branded and private label sales, the inability to enforce or protect our intellectual property rights against infringement, the inability to achieve cost savings and operational efficiencies, the inability to increase operating margins and increase revenues, dependence on individual products, dependence on individual customers, the impact of competitive products and pricing (including private label), market and industry conditions (including pricing, demand for products and level of trade inventories), the impact of clinical studies regarding nutritional supplements, particularly relating to the joint care category, the success of product development, the inability to obtain customer acceptance of new product introductions, changes in laws and regulations, litigation and government regulatory action in the United States and internationally, the inability or increased cost to obtain product liability and general insurance, the uncertainty of market acceptance of new products, adverse publicity regarding the consumption of nutritional supplements, the inability to find strategic acquisitions or the inability to successfully consummate or integrate an acquisition, changes in accounting standards, and other factors indicated from time to time in the company's SEC reports, copies of which are available upon request from the company's investor relations department or may be obtained at the SEC's web site ( These risks and uncertainties should be carefully considered before making an investment decision with respect to shares of our common stock.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.